All posts in category Herpes Zoster/Shingles

Study finds Shingles (Herpes Zoster) Vaccine Safe

PASADENA, Calif. — The herpes zoster vaccine, also known as the shingles vaccine, is generally safe and well tolerated according to a Vaccine Safety Datalink study of 193,083 adults published online in the Journal of Internal Medicine. More than 1 million people develop shingles every year in the United States. Shingles is a painful contagious [...]

Shingles may be related to elevated risk of multiple sclerosis

Taiwanese investigators have found that there can be a significantly higher risk of multiple sclerosis (MS) occurring in the year following a shingles, or herpes zoster, attack. The findings, which support a long-held view on how MS may develop, are published in The Journal of Infectious Diseases and now available online (http://jid.oxfordjournals.org/content/early/2011/06/07/infdis.jir239.abstract). MS is an [...]

Researches Develop Novel Anti-Shingles Agent

Athens, Ga. – Researchers at the University of Georgia and Yale University have discovered a compound with the potential to be more effective than existing agents in treating the very painful blisters known as shingles—a condition that affects up to 30 percent of Americans, mostly elderly, and for which no specific treatment exists. Most adults [...]

FDA approves Zostavax vaccine to prevent shingles in individuals 50 to 59 years of age

The Food and Drug Administration (FDA) today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older. In the United States shingles affects approximately 200,000 healthy people between [...]

Recurrent Shingles May be More Common than Previously Thought

ROCHESTER, Minn. — 1-Feb-2011 For decades, medical wisdom about shingles has been that it’s a once-in-a-lifetime experience. The commonly-held belief is that patients are protected from a recurrence of the herpes zoster virus, which causes shingles, after one episode. But according to a study published in the February issue of Mayo Clinic Proceedings, recurrences of [...]

Shingles Vaccine and Reduction in Number of Shingles Cases

Journal of the American Medical Association Abstract: January 2011: In the article by Hung Fu Tseng, et al Herpes Zoster Vaccine in Older Adults and the Risk of Subsequent Herpes Zoster Disease the authors goal was to evaluate risk of herpes zoster after receipt of herpes zoster vaccine among individuals in general practice settings. They [...]

Shingles Patient Information from JAMA

From the Journal of the American Medical Association January 2011 Shingles is a painful condition caused by the virus that also causes chickenpox ( varicella-zoster virus, or VZV). It affects about 1 million individuals per year in the United States alone. Shingles, also known as herpes zoster, occurs in persons who have already had chickenpox. [...]

Zoster Vaccine Associated With Lower Risk of Shingles in Older Adults

CHICAGO—Vaccination for herpes zoster, a painful rash commonly known as shingles, among a large group of older adults was associated with a reduced risk of this condition, regardless of age, race or the presence of chronic diseases, according to a study in the January 12 issue of JAMA. “The pain of herpes zoster is often [...]